Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Jun 08, 2014 10:33am
181 Views
Post# 22640941

RE:why the silence?

RE:why the silence?Hi ko-be-won. These are great questions.

I would think that if it was confirmed that a deal was in serious negotiations it would drive the stock price up significantly. In Februrary Don indicated that the initial payment in a CVR would be pegged to the stock price at some point in time e.g. at current share prices that might mean the initial payout might be $1.00 or $1.10. I said this on a previous post and was scolded by another poster who said Don would never accept $1.00 and I'm sure KD would never accept a dollar.....thank heavens. So if the share price was driven up by awareness of deal discussions the cost of the CVR could be much higher.

So my belief at this stage remains that the cone of silence is because there is a deal or deals being dicussed with various suitors...IMO.

Possibly part of the slow progress, as has been posted before, may be to dis-entangle Zenith and RVX.

Don said in February that any proposed CVR would require a vote by all shareholders. Let's hope it is proposed soon.

Cheers
Toinv
Bullboard Posts